Peter Cicala
Direktor/Vorstandsmitglied bei ETERNA THERAPEUTICS INC.
Aktive Positionen von Peter Cicala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ETERNA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 12.02.2024 | - |
| Independent Dir/Board Member | 12.02.2024 | - |
Karriereverlauf von Peter Cicala
Ehemalige bekannte Positionen von Peter Cicala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2020 | 01.03.2021 |
| CELGENE | Corporate Officer/Principal | 01.03.2014 | 01.11.2019 |
| BOUNDLESS BIO, INC. | Gründer | 01.11.2019 | - |
Ausbildung von Peter Cicala
| Seton Hall University School of Law | Graduate Degree |
| Fairleigh Dickinson University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Peter Cicala
- Erfahrung
